Cargando…

Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response

We lack a mechanistic understanding of aging-mediated changes in mitochondrial bioenergetics and lipid metabolism that affect T cell function. The bioactive sphingolipid ceramide, induced by aging stress, mediates mitophagy and cell death; however, the aging-related roles of ceramide metabolism in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaena, Silvia, Chakraborty, Paramita, Lee, Han Gyul, Janneh, Alhaji H., Kassir, Mohamed Faisal, Beeson, Gyda, Hedley, Zachariah, Yalcinkaya, Ahmet, Sofi, M. Hanief, Li, Hong, Husby, Monica L., Stahelin, Robert V., Yu, Xue-Zhong, Mehrotra, Shikhar, Ogretmen, Besim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127241/
https://www.ncbi.nlm.nih.gov/pubmed/33951438
http://dx.doi.org/10.1016/j.celrep.2021.109076
Descripción
Sumario:We lack a mechanistic understanding of aging-mediated changes in mitochondrial bioenergetics and lipid metabolism that affect T cell function. The bioactive sphingolipid ceramide, induced by aging stress, mediates mitophagy and cell death; however, the aging-related roles of ceramide metabolism in regulating T cell function remain unknown. Here, we show that activated T cells isolated from aging mice have elevated C14/C16 ceramide accumulation in mitochondria, generated by ceramide synthase 6, leading to mitophagy/mitochondrial dysfunction. Mechanistically, aging-dependent mitochondrial ceramide inhibits protein kinase A, leading to mitophagy in activated T cells. This aging/ceramide-dependent mitophagy attenuates the antitumor functions of T cells in vitro and in vivo. Also, inhibition of ceramide metabolism or PKA activation by genetic and pharmacologic means prevents mitophagy and restores the central memory phenotype in aging T cells. Thus, these studies help explain the mechanisms behind aging-related dysregulation of T cells’ antitumor activity, which can be restored by inhibiting ceramide-dependent mitophagy.